These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23469749)

  • 1. [Good prognosis studies can provide better clinical decisions. Validated risk-/prognosis factors helps the physician].
    Fall K; Holmberg L; Sundström J
    Lakartidningen; 2013 Feb 6-12; 110(6):279-83. PubMed ID: 23469749
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk prediction models: II. External validation, model updating, and impact assessment.
    Moons KG; Kengne AP; Grobbee DE; Royston P; Vergouwe Y; Altman DG; Woodward M
    Heart; 2012 May; 98(9):691-8. PubMed ID: 22397946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making decisions about prognosis in evidence-based practice.
    Degen RM; Hoppe DJ; Petrisor BA; Bhandari M
    Hand Clin; 2009 Feb; 25(1):59-66, vi. PubMed ID: 19232916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better environmental decision making - recent progress and future trends.
    Pollard SJ; Davies GJ; Coley F; Lemon M
    Sci Total Environ; 2008 Aug; 400(1-3):20-31. PubMed ID: 18774589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic nomogram for terminally ill cancer patients.
    Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
    J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can nomograms be superior to other prediction tools?
    Shariat SF; Capitanio U; Jeldres C; Karakiewicz PI
    BJU Int; 2009 Feb; 103(4):492-5; discussion 495-7. PubMed ID: 18990135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms for bladder cancer.
    Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination.
    Sundström J; Byberg L; Gedeborg R; Michaëlsson K; Berglund L
    Scand J Public Health; 2011 Jun; 39(4):439-41. PubMed ID: 21270137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of advances in technology for maritime risk assessment.
    Wang J; Sii HS; Yang JB; Pillay A; Yu D; Liu J; Maistralis E; A Saajedi
    Risk Anal; 2004 Aug; 24(4):1041-63. PubMed ID: 15357827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use and abuse of data: nomograms and talking to patients about clinical medicine.
    Lerner SP; Bochner B; Kibel AS
    Urol Oncol; 2007; 25(4):333-7. PubMed ID: 17628303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and prognostic factors in the post-myocardial infarction patient.
    Cannon CP; Greenberg BH
    Am J Cardiol; 2008 Sep; 102(5A):13G-20G. PubMed ID: 18722187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of clinically useful measures of the consequences of treatment.
    Laupacis A; Sackett DL; Roberts RS
    N Engl J Med; 1988 Jun; 318(26):1728-33. PubMed ID: 3374545
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
    Gallina A; Chun FK; Briganti A; Shariat SF; Montorsi F; Salonia A; Erbersdobler A; Rigatti P; Valiquette L; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2007 Jul; 52(1):98-105. PubMed ID: 17267098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation, expression and perception of risk in medicine: implications for clinical decision-making.
    Costa J; Carneiro AV
    Rev Port Cardiol; 2011 Jan; 30(1):95-119. PubMed ID: 21425747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis assessment in malignant melanoma: relevance for decisions regarding adjuvant therapies and after care].
    Sterry W
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):171. PubMed ID: 18315620
    [No Abstract]   [Full Text] [Related]  

  • 20. Making decisions about benefits and harms of medicines.
    Greenhalgh T; Kostopoulou O; Harries C
    BMJ; 2004 Jul; 329(7456):47-50. PubMed ID: 15231628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.